The DOI matches its Crossref record.
Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis
Abstract
Objective. To study the effect of chimeric anti‐CD4 monoclonal antibody (MAb) therapy on synovial inflammation, in order to interpret the clinical experience with anti‐CD4 treatment. Methods. The immunohistologic features of synovial biopsy specimens before and 4 weeks after anti‐CD4 MAb (cM‐T412) therapy were studied in patients with rheumatoid arthritis. The patients received intravenous doses of either placebo (n = 1) or 10 mg (n = 4), 25 mg (n = 2), or 50 mg (n = 1) of cM‐T412 daily for 5 consecutive days. Results. Although the patients did not experience clinical improvement, significant decreases in the number of circulating CD4+ cells, the degree of synovial inflammatory infiltration, and the mean scores for expression of adhesion molecules were found in the 7 patients 4 weeks after receiving cM‐T412. The scores for infiltration with CD4+ and other inflammatory cells were particularly reduced following treatment with either 25 mg or 50 mg cM‐T412. Cytokines, such as interleukin‐1β and tumor necrosis factor α, could still be detected in the synovial tissue after treatment. Conclusion. The decline in the numbers of inflammatory cells and adhesion molecules in synovial tissue after CD4+ cell depletion supports the view that CD4+ T cells orchestrate local cellular infiltration. The lack of clinical effect of anti‐CD4 therapy might be explained by an insufficient decrease in the number of synovial CD4+ cells and by the persistence of cytokines. Determination of whether more adequate dosing would lead to a clinical improvement must await further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tak, P. P., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meijers, K. A. E., Brand, R., Meinders, A. E., & Breedveld, F. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400206 · Cited by 548
Self-citationHaringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J. M., Kraan, M. C., Baeten, D., McInnes, I. B., Bresnihan, B., & Tak, P. P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029751 · Cited by 457
Self-citationTak, P. P., Taylor, P. C., Breedveld, F. C., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meinders, A. E., & Maini, R. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390702 · Cited by 377
Self-citationKrenn, V., Morawietz, L., Häupl, T., Neidel, J., Petersen, I., & König, A. (2002) · Pathology - Research and Practice · doi:10.1078/0344-0338-5710261 · Cited by 330
Möttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
Metadata
- Authors
- Tak, P. P., Van Der Lubbe, P. A., Cauli, A., Daha, M. R., Smeets, T. J. M., Kluin, P. M., Meinders, A. E., Yanni, G., Panayi, G. S., & Breedveld, F. C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1995-10
- Volume
- 38
- Issue
- 10
- Pages
- 1457-1465
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2048341382
- Cited by
- 193
- References
- 0
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.1780381012
- The paper
- Tak, P. P., Van Der Lubbe, P. A., Cauli, A., Daha, M. R., Smeets, T. J. M., Kluin, P. M., Meinders, A. E., Yanni, G., Panayi, G. S., & Breedveld, F. C. (1995). Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780381012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.